These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


131 related items for PubMed ID: 1940122

  • 21. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV, Valencia I, Khurana DS, Hardison H, Melvin JJ, Legido A.
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [Abstract] [Full Text] [Related]

  • 22. [New antiepileptic drugs: new therapeutic options].
    Baulac M.
    Rev Neurol (Paris); 2002 May; 158(5 Pt 2):4S46-54. PubMed ID: 11997751
    [Abstract] [Full Text] [Related]

  • 23. [New antiepileptic drugs in childhood epilepsies: indications and limits].
    Kaminska A.
    Epileptic Disord; 2001 May; 3 Spec No 2():SI37-46. PubMed ID: 11827845
    [Abstract] [Full Text] [Related]

  • 24. Discontinuing antiepileptic drugs in children with epilepsy. A comparison of a six-week and a nine-month taper period.
    Tennison M, Greenwood R, Lewis D, Thorn M.
    N Engl J Med; 1994 May 19; 330(20):1407-10. PubMed ID: 8159193
    [Abstract] [Full Text] [Related]

  • 25. Vigabatrin.
    Michelucci R, Tassinari CA.
    Epilepsy Res Suppl; 1991 May 19; 3():193-6. PubMed ID: 1777080
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effect of long-term vigabatrin therapy on selected neurotransmitter concentrations in cerebrospinal fluid.
    Ben-Menachem E, Persson LI, Mumford J, Haegele KD, Huebert N.
    J Child Neurol; 1991 May 19; Suppl 2():S11-6. PubMed ID: 1719063
    [Abstract] [Full Text] [Related]

  • 28. Neuropathologic findings in patients receiving long-term vigabatrin therapy for chronic intractable epilepsy.
    Cannon DJ, Butler WH, Mumford JP, Lewis PJ.
    J Child Neurol; 1991 May 19; Suppl 2():S17-24. PubMed ID: 1940119
    [Abstract] [Full Text] [Related]

  • 29. Vigabatrin in the treatment of epilepsy in children.
    Livingston JH, Beaumont D, Arzimanoglou A, Aicardi J.
    Br J Clin Pharmacol; 1989 May 19; 27 Suppl 1(Suppl 1):109S-112S. PubMed ID: 2757901
    [Abstract] [Full Text] [Related]

  • 30. Vigabatrin.
    Mumford JP, Lewis PJ.
    Epilepsy Res Suppl; 1991 May 19; 3():161-8. PubMed ID: 1777075
    [No Abstract] [Full Text] [Related]

  • 31. Vigabatrin--plasma enantiomer concentrations and clinical effects.
    Sheean G, Schramm T, Anderson DS, Eadie MJ.
    Clin Exp Neurol; 1992 May 19; 29():107-16. PubMed ID: 1343855
    [Abstract] [Full Text] [Related]

  • 32. Vigabatrin: a new antiepileptic medication.
    Mumford J, Dulac O.
    J Child Neurol; 1991 May 19; Suppl 2():S3-6. PubMed ID: 1940121
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Clobazam in the treatment of Lennox-Gastaut syndrome.
    Conry JA, Ng YT, Paolicchi JM, Kernitsky L, Mitchell WG, Ritter FJ, Collins SD, Tracy K, Kormany WN, Abdulnabi R, Riley B, Stolle J.
    Epilepsia; 2009 May 19; 50(5):1158-66. PubMed ID: 19170737
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.